Our top pick for
Servotronics Inc is an electrical equipment & parts business based in the US. Servotronics shares (SVT) are listed on the NYSE MKT and all prices are listed in US Dollars. Servotronics employs 316 staff and has a trailing 12-month revenue of around 0.00.
|Latest market close||$11.66|
|52-week range||$7.10 - $12.45|
|50-day moving average||$11.75|
|200-day moving average||$9.29|
|Wall St. target price||N/A|
|Dividend yield||$0 (0%)|
|Earnings per share (TTM)||$-0.44|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2021-10-15)||-1.02%|
|1 month (2021-09-24)||-2.81%|
|3 months (2021-07-23)||38.97%|
|6 months (2021-04-23)||47.78%|
|1 year (2020-10-23)||42.20%|
|2 years (2019-10-23)||14.08%|
|3 years (2018-10-23)||14.88%|
|5 years (2016-10-21)||0.53%|
Valuing Servotronics stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Servotronics's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Servotronics's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $1.7 million.
The EBITDA is a measure of a Servotronics's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||$40 million|
|Gross profit TTM||$8.2 million|
|Return on assets TTM||-5.51%|
|Return on equity TTM||-2.88%|
|Market capitalisation||$29.4 million|
TTM: trailing 12 months
There are currently 24,247 Servotronics shares held short by investors – that's known as Servotronics's "short interest". This figure is 32.1% down from 35,734 last month.
There are a few different ways that this level of interest in shorting Servotronics shares can be evaluated.
Servotronics's "short interest ratio" (SIR) is the quantity of Servotronics shares currently shorted divided by the average quantity of Servotronics shares traded daily (recently around 5498.1859410431). Servotronics's SIR currently stands at 4.41. In other words for every 100,000 Servotronics shares traded daily on the market, roughly 4410 shares are currently held short.
However Servotronics's short interest can also be evaluated against the total number of Servotronics shares, or, against the total number of tradable Servotronics shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Servotronics's short interest could be expressed as 0.01% of the outstanding shares (for every 100,000 Servotronics shares in existence, roughly 10 shares are currently held short) or 0.0263% of the tradable shares (for every 100,000 tradable Servotronics shares, roughly 26 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Servotronics.
Find out more about how you can short Servotronics stock.
We're not expecting Servotronics to pay a dividend over the next 12 months.
Servotronics's shares were split on a 108:100 basis on 28 May 1996. So if you had owned 100 shares the day before before the split, the next day you'd have owned 108 shares. This wouldn't directly have changed the overall worth of your Servotronics shares – just the quantity. However, indirectly, the new 7.4% lower share price could have impacted the market appetite for Servotronics shares which in turn could have impacted Servotronics's share price.
Over the last 12 months, Servotronics's shares have ranged in value from as little as $7.1 up to $12.45. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE MKT average) beta is 1, while Servotronics's is 0.9053. This would suggest that Servotronics's shares are less volatile than average (for this exchange).
Servotronics, Inc. designs, manufactures, and markets control components and consumer products in the United States and internationally. It operates in two segments, Advanced Technology Group (ATG) and Consumer Products Group (CPG). The ATG segment provides servo-control components to the commercial aerospace, aircraft, and government related industries; and medical and industrial markets. This segment's principal components include torque motors, electromagnetic actuators, hydraulic and pneumatic valves, and related devices that convert an electrical current into a mechanical force or movement, and other products. It also offers metallic seals of various cross-sectional configurations to close tolerances from standard and special alloy steels. This segment markets and sells its products to the United States Government, government prime contractors, government subcontractors, commercial manufacturers, and end-users.
Steps to owning and managing ProShares Bitcoin Strategy ETF units.
Everything we know about the The Real Good Food Company IPO, plus information on how to buy in.
Everything we know about the Lulu’s Fashion Lounge Holdings IPO, plus information on how to buy in.
Everything we know about the Allarity Therapeutics IPO, plus information on how to buy in.
Everything we know about the Jupiter Neurosciences IPO, plus information on how to buy in.
Everything we know about the Mainz Biomed IPO, plus information on how to buy in.
Everything we know about the Progressive Care IPO, plus information on how to buy in.
Everything we know about the Desert Peak Minerals IPO, plus information on how to buy in.
Everything we know about the Vaxxinity IPO, plus information on how to buy in.
Everything we know about the Entrada Therapeutics IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.